Biosense Webster Announces CE Mark approval in Europe for VARIPULSE™ Pulsed Field Ablation (PFA) Platform

/PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, today announced European CE mark...

Related Keywords

United States ,Boston ,Massachusetts ,Japan ,California ,United Kingdom ,Belgium ,Aalst ,Region Flamande ,Canada ,Irvine ,British ,Johnson Medtech ,Biosense Webster ,Rebecca Ratcliffe ,Tracy Menkowski ,Johanep Waktare ,Prnewswire Biosense Webster Inc ,British Heart Foundation ,Cardiovascular Center ,Exchange Commission ,Linkedin ,Biosense Webster Inc ,Johnson Biosense Webster Inc ,None Biosense Webster Inc ,Johnson ,Twitter ,Cardiac Mapping System ,Atrial Tachycardia ,Atrial Flutter ,Tom De Potter ,Associate Director ,Jasmina Brooks ,Private Securities Litigation Reform Act ,Annual Report ,Note Regarding Forward Looking ,Quarterly Reports ,None Biosense Webster ,Johnson Biosense Webster ,Paroxysmal Atrial Fibrillation ,Pulsed Field Ablation ,System With Irreversible Electroporation ,Mapping System ,One Year Outcomes ,Field Ablation ,Pulmonary Vein Isolation ,Atrial Fibrillation ,New Millennium Epidemic ,